Protagenic Therapeutics Inc (PTIX)
1.375
+0.08
(+5.77%)
USD |
NASDAQ |
May 02, 16:00
Protagenic Therapeutics Max Drawdown (5Y): 99.40% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.40% |
| March 31, 2024 | 99.40% |
| February 29, 2024 | 99.40% |
| January 31, 2024 | 99.40% |
| December 31, 2023 | 99.40% |
| November 30, 2023 | 99.40% |
| October 31, 2023 | 99.40% |
| September 30, 2023 | 99.40% |
| August 31, 2023 | 99.40% |
| July 31, 2023 | 99.40% |
| June 30, 2023 | 99.40% |
| May 31, 2023 | 99.40% |
| April 30, 2023 | 99.40% |
| March 31, 2023 | 99.40% |
| February 28, 2023 | 99.40% |
| January 31, 2023 | 99.40% |
| December 31, 2022 | 99.40% |
| November 30, 2022 | 99.40% |
| October 31, 2022 | 99.40% |
| September 30, 2022 | 99.40% |
| August 31, 2022 | 99.40% |
| July 31, 2022 | 99.40% |
| June 30, 2022 | 99.40% |
| May 31, 2022 | 99.40% |
| April 30, 2022 | 99.40% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.40% |
| February 28, 2022 | 99.40% |
| January 31, 2022 | 99.73% |
| December 31, 2021 | 99.90% |
| November 30, 2021 | 99.90% |
| October 31, 2021 | 99.90% |
| September 30, 2021 | 99.90% |
| August 31, 2021 | 99.90% |
| July 31, 2021 | 99.90% |
| June 30, 2021 | 99.91% |
| May 31, 2021 | 99.98% |
| April 30, 2021 | 100.00% |
| March 31, 2021 | 100.00% |
| February 28, 2021 | 100.00% |
| January 31, 2021 | 100.00% |
| December 31, 2020 | 100.00% |
| November 30, 2020 | 100.00% |
| October 31, 2020 | 100.00% |
| September 30, 2020 | 100.00% |
| August 31, 2020 | 100.00% |
| July 31, 2020 | 100.00% |
| June 30, 2020 | 100.00% |
| May 31, 2020 | 100.00% |
| April 30, 2020 | 100.00% |
| March 31, 2020 | 100.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.40%
Minimum
Feb 2022
100.00%
Maximum
May 2019
99.71%
Average
99.90%
Median
Jul 2021
Max Drawdown (5Y) Benchmarks
| Ekso Bionics Holdings Inc | 98.23% |
| Eyenovia Inc | 93.03% |
| Palisade Bio Inc | 99.99% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -36.68 |
| Beta (5Y) | 0.445 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 127.8% |
| Historical Sharpe Ratio (5Y) | -0.2482 |
| Historical Sortino (5Y) | -0.6191 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.76% |